n affordable price to the Southern African market, but will also mean a further investment of approximately R100 million in the local economy."

Ranbaxy is also planning a major upgrade of the Be-Tabs manufacturing facility to bring its factories in line with new standards. With the re-vamp of the Be-Tabs facilities, the company expects to lead the way for generics manufacturing in South Africa. The acquisition of Be-Tabs substantially strengthens the basket of products that Ranbaxy brings to the market - especially in the acute and over the counter product streams. The company expects to use the brand equity that Be-Tabs has acquired to leverage market share among wholesalers, pharmacies, dispensing doctors and consumers.

Ranjan Chakravarti, Ranbaxy's Regional Director Africa and Latin America, added: "Ranbaxy entered South Africa with a business model that aimed to meet the country's need for access to affordable healthcare for a wide cross-section of the population. This acquisition - with its market presence and substantive manufacturing capabilities - is another step towards achieving this goal. "

Ranbaxy established a presence in South Africa in 1996 and has been rewarded with excellent growth in the past decade. The acquisition of Be-Tabs is expected to boost earnings by more than double.

Be-Tabs Pharmaceuticals (Pty) Ltd is the largest manufacturer of Penicillin formulations in South Africa and markets & manufactures a portfolio of ethical and over-the-counter (OTC) solid-oral and liquid formulations in South Africa. The Company actively participates in local and export tenders in the African Continent. With sales of approximately USD 30 Million, Be-Tabs is the fifth largest generic company in South Africa and one of the most profitable companies in the market. Be-Tabs Pharmaceuticals (Pty) Ltd was founded in Johannesburg, South Africa, in 1974 and focuses on producing the highest quality products in a co
'"/>




Page: 1 2 3
Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy gets US FDA approval for Lisinopril
3. Ranbaxy Labs Entry Into Anti-Acne Market
4. Ranbaxy trying to make inroads in herbal drugs market
5. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Ranbaxy opens Drug discovery centre in Gurgaon
8. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
9. SRL Ranbaxy offers quicker bird flu diagnostic test
10. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
11. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients